Bio ACL Reconstruction Amnion Collagen Matrix Wrap and Stem Cells (BioACLRCT)
Primary Purpose
ACL - Anterior Cruciate Ligament Rupture
Status
Active
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
Bio ACL
Control
Sponsored by
About this trial
This is an interventional treatment trial for ACL - Anterior Cruciate Ligament Rupture focused on measuring amion, stem cell, acl
Eligibility Criteria
Inclusion Criteria:
- Patients between the ages of 18 and 45 who are scheduled to have anterior cruciate ligament reconstruction with autologous grafts by one of the investigating physicians will be screened for participation in this study.
- Patients must be willing to undergo MRI scans post -operatively at 3, 6, 9 months and 1 year
Exclusion Criteria:
- Patients with prior procedures or significant prior injuries to the same knee are excluded. - - Any patient who will have difficulty obtaining internet access, does not have an active e-mail address, or is unable to comprehend study documents or give informed consent will be excluded.
- Patient who are unable to complete MRI examinations due to claustrophobia or anxiety will be excluded.
Sites / Locations
- Andrews Institute
Arms of the Study
Arm 1
Arm 2
Arm Type
Experimental
Active Comparator
Arm Label
Bio-ACL (Amion)
Control
Arm Description
Intervention: ACL Autograft Reconstruction with Amion Collagen Scaffold. Stem Cells isolated from bone marrow aspirate from distal femur will be injected inside the Amion Collagen Scaffold.
Intervention: Normal ACL Autograft Reconstruction with either patella or hamstring autograft will be performed in the control group.
Outcomes
Primary Outcome Measures
Changes in ACL
MRI region of interest mapping to produce mean T2 values
Secondary Outcome Measures
Changes in patient-reported pain rating
Visual analog scale will be used to assess pain
Changes in Knee injury and Osteoarthritis Outcome Score (KOOS)
Patients will complete KOOS questionnaire on SOS
Changes in Short Form 12 (SF-12) patient ratings
Patients will complete SF-12 questionnaire on SOS
Changes in Single Assessment Numerical Evaluation (SANE) patient ratings for function
Patients will complete the SANE questionnaire on SOS
Marx Activity Scale Rating
Patients will complete the Marx Activity questionnaire on SOS
Full Information
NCT ID
NCT03294759
First Posted
September 20, 2017
Last Updated
January 30, 2023
Sponsor
Andrews Research & Education Foundation
Collaborators
Arthrex, Inc.
1. Study Identification
Unique Protocol Identification Number
NCT03294759
Brief Title
Bio ACL Reconstruction Amnion Collagen Matrix Wrap and Stem Cells
Acronym
BioACLRCT
Official Title
Pilot Study: Augmentation of ACL Reconstruction With Bone Marrow Stem Cells and Amnion Collagen Matrix Wrap
Study Type
Interventional
2. Study Status
Record Verification Date
January 2023
Overall Recruitment Status
Active, not recruiting
Study Start Date
September 6, 2017 (Actual)
Primary Completion Date
December 6, 2023 (Anticipated)
Study Completion Date
December 6, 2023 (Anticipated)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Andrews Research & Education Foundation
Collaborators
Arthrex, Inc.
4. Oversight
Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Product Manufactured in and Exported from the U.S.
No
Data Monitoring Committee
Yes
5. Study Description
Brief Summary
Collagen based -membrane derived from amniotic tissue can be used to help reestablish the natural synovial lining of the reconstructed ACL, in effect acting as both a barrier from the synovial fluid and as a scaffold to contain autologous mesenchymal stem cells and growth factors contiguous with the graft, thus aiding and perhaps accelerating the natural maturation and ligamentization process of the implanted graft tissue. Acceleration and improvement in graft maturation and strength would be a significant advancement in sports medicine allowing safer and earlier return to sports and activity
Detailed Description
Histologic studies have determined that graft ligamentization following anterior cruciate ligament (ACL) reconstruction may take from 6 to 18 months. (1) It has been reported that incomplete graft maturation and incorporation is one cause of clinical graft failure. Animal studies have illustrated improved tendon healing/integration in ACL models augmented with stem cell technologies. (2-4). Basic scientists theorize that optimization of stem cell treatments for tissue regeneration requires that a "regenerative triad" be employed, i.e., use of a scaffold, stem cells and growth factors. In the intra-articular environment, research has shown that a scaffold such as an amnion wrap is necessary to contain the stem cells and growth factors in close proximity to the ACL graft. (2, 4, 5)
The normal, uninjured human ACL is covered by a layer of synovial tissue which contributes to the blood supply and nutrition of the native ACL. It is theorized that the lack of a synovial lining after injury and following traditional ACL reconstruction contributes to slow ligamentization and possible failure of reconstructed grafts.(5) Two studies have demonstrated accelerated maturation and ligamentization of human ACL graft augmented with point of care blood products. (6, 7) In one, leucocyte poor platelet rich plasma was injected directly into the body of the graft. (6) In the other, the platelet derived growth factors were loaded in a gelatin carrier which was wrapped around the graft. (7) In both studies accelerated and increased ligament maturation was documented compared to the controls. Collagen membranes derived from amniotic tissue have been successful to aid healing when used in difficult wounds and meniscal repair surgery. (8, 9)
The use of a collagen based -membrane derived from amniotic tissue may be used to help reestablish the natural synovial lining of the reconstructed ACL, in effect acting as both a barrier from the synovial fluid and as a scaffold to contain autologous mesenchymal stem cells and growth factors contiguous with the graft. Thus aiding and perhaps accelerating the natural maturation and ligamentization process of the implanted graft tissue. Acceleration and improvement in graft maturation and strength would be a significant advancement in sports medicine allowing safer and earlier return to sports and activity.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
ACL - Anterior Cruciate Ligament Rupture
Keywords
amion, stem cell, acl
7. Study Design
Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Model Description
ACL harvested for autograft reconstruction of the ACL with either hamstring or patellar tendon grafts. The graft will be wrapped in a collagen wrap and injection with aspirate from the patient's bone marrow.
The control group will have standard ACL reconstruction with either hamstring or patellar tendon grafts.
Masking
ParticipantOutcomes Assessor
Masking Description
Bone marrow aspirate will be collected through the surgical site from the distal femur with a trocar designed for this purpose. Therefore patients will be unable to determine if they have had stem cells harvested
Allocation
Randomized
Enrollment
40 (Actual)
8. Arms, Groups, and Interventions
Arm Title
Bio-ACL (Amion)
Arm Type
Experimental
Arm Description
Intervention: ACL Autograft Reconstruction with Amion Collagen Scaffold. Stem Cells isolated from bone marrow aspirate from distal femur will be injected inside the Amion Collagen Scaffold.
Arm Title
Control
Arm Type
Active Comparator
Arm Description
Intervention: Normal ACL Autograft Reconstruction with either patella or hamstring autograft will be performed in the control group.
Intervention Type
Other
Intervention Name(s)
Bio ACL
Other Intervention Name(s)
Amnion
Intervention Description
Bone marrow aspirate will be centrifuged using the Arthrex Angel system to optimally concentrate the cells for implantation. The graft for the experimental groups will be wrapped with a sterile amnion matrix wrap, supplied by Arthrex
Intervention Type
Other
Intervention Name(s)
Control
Other Intervention Name(s)
Standard ACLr
Intervention Description
Normal ACL reconstruction technique with either patella or hamstring autograft
Primary Outcome Measure Information:
Title
Changes in ACL
Description
MRI region of interest mapping to produce mean T2 values
Time Frame
3 months, 6 months, 9 months, 12 months post-op
Secondary Outcome Measure Information:
Title
Changes in patient-reported pain rating
Description
Visual analog scale will be used to assess pain
Time Frame
3 months, 6 months, 9 months, 12 months post-op
Title
Changes in Knee injury and Osteoarthritis Outcome Score (KOOS)
Description
Patients will complete KOOS questionnaire on SOS
Time Frame
3 months, 6 months, 9 months, 12 months post-op
Title
Changes in Short Form 12 (SF-12) patient ratings
Description
Patients will complete SF-12 questionnaire on SOS
Time Frame
3 months, 6 months, 9 months, 12 months post-op
Title
Changes in Single Assessment Numerical Evaluation (SANE) patient ratings for function
Description
Patients will complete the SANE questionnaire on SOS
Time Frame
3 months, 6 months, 9 months, 12 months post-op
Title
Marx Activity Scale Rating
Description
Patients will complete the Marx Activity questionnaire on SOS
Time Frame
12 months post-op
10. Eligibility
Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
45 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria:
Patients between the ages of 18 and 45 who are scheduled to have anterior cruciate ligament reconstruction with autologous grafts by one of the investigating physicians will be screened for participation in this study.
Patients must be willing to undergo MRI scans post -operatively at 3, 6, 9 months and 1 year
Exclusion Criteria:
Patients with prior procedures or significant prior injuries to the same knee are excluded. - - Any patient who will have difficulty obtaining internet access, does not have an active e-mail address, or is unable to comprehend study documents or give informed consent will be excluded.
Patient who are unable to complete MRI examinations due to claustrophobia or anxiety will be excluded.
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Adam Anz, MD
Organizational Affiliation
Andrews Research & Education Foundation
Official's Role
Principal Investigator
Facility Information:
Facility Name
Andrews Institute
City
Gulf Breeze
State/Province
Florida
ZIP/Postal Code
32561
Country
United States
12. IPD Sharing Statement
Citations:
PubMed Identifier
21515806
Citation
Claes S, Verdonk P, Forsyth R, Bellemans J. The "ligamentization" process in anterior cruciate ligament reconstruction: what happens to the human graft? A systematic review of the literature. Am J Sports Med. 2011 Nov;39(11):2476-83. doi: 10.1177/0363546511402662. Epub 2011 Apr 22.
Results Reference
background
PubMed Identifier
22427618
Citation
Matsumoto T, Kubo S, Sasaki K, Kawakami Y, Oka S, Sasaki H, Takayama K, Tei K, Matsushita T, Mifune Y, Kurosaka M, Kuroda R. Acceleration of tendon-bone healing of anterior cruciate ligament graft using autologous ruptured tissue. Am J Sports Med. 2012 Jun;40(6):1296-302. doi: 10.1177/0363546512439026. Epub 2012 Mar 16.
Results Reference
background
PubMed Identifier
23632324
Citation
Mifune Y, Matsumoto T, Takayama K, Terada S, Sekiya N, Kuroda R, Kurosaka M, Fu FH, Huard J. Tendon graft revitalization using adult anterior cruciate ligament (ACL)-derived CD34+ cell sheets for ACL reconstruction. Biomaterials. 2013 Jul;34(22):5476-87. doi: 10.1016/j.biomaterials.2013.04.013. Epub 2013 Apr 28.
Results Reference
background
PubMed Identifier
19940313
Citation
Joshi SM, Mastrangelo AN, Magarian EM, Fleming BC, Murray MM. Collagen-platelet composite enhances biomechanical and histologic healing of the porcine anterior cruciate ligament. Am J Sports Med. 2009 Dec;37(12):2401-10. doi: 10.1177/0363546509339915.
Results Reference
background
PubMed Identifier
20362825
Citation
Sanchez M, Anitua E, Azofra J, Prado R, Muruzabal F, Andia I. Ligamentization of tendon grafts treated with an endogenous preparation rich in growth factors: gross morphology and histology. Arthroscopy. 2010 Apr;26(4):470-80. doi: 10.1016/j.arthro.2009.08.019. Epub 2010 Jan 15.
Results Reference
background
PubMed Identifier
20117627
Citation
Radice F, Yanez R, Gutierrez V, Rosales J, Pinedo M, Coda S. Comparison of magnetic resonance imaging findings in anterior cruciate ligament grafts with and without autologous platelet-derived growth factors. Arthroscopy. 2010 Jan;26(1):50-7. doi: 10.1016/j.arthro.2009.06.030.
Results Reference
background
PubMed Identifier
27826487
Citation
DiDomenico LA, Orgill DP, Galiano RD, Serena TE, Carter MJ, Kaufman JP, Young NJ, Zelen CM. Aseptically Processed Placental Membrane Improves Healing of Diabetic Foot Ulcerations: Prospective, Randomized Clinical Trial. Plast Reconstr Surg Glob Open. 2016 Oct 12;4(10):e1095. doi: 10.1097/GOX.0000000000001095. eCollection 2016 Oct.
Results Reference
background
PubMed Identifier
27047635
Citation
Piontek T, Ciemniewska-Gorzela K, Naczk J, Jakob R, Szulc A, Grygorowicz M, Slomczykowski M. Complex Meniscus Tears Treated with Collagen Matrix Wrapping and Bone Marrow Blood Injection: A 2-Year Clinical Follow-Up. Cartilage. 2016 Apr;7(2):123-39. doi: 10.1177/1947603515608988. Epub 2015 Nov 30.
Results Reference
background
PubMed Identifier
22495290
Citation
Li H, Tao H, Cho S, Chen S, Yao Z, Chen S. Difference in graft maturity of the reconstructed anterior cruciate ligament 2 years postoperatively: a comparison between autografts and allografts in young men using clinical and 3.0-T magnetic resonance imaging evaluation. Am J Sports Med. 2012 Jul;40(7):1519-26. doi: 10.1177/0363546512443050. Epub 2012 Apr 11.
Results Reference
background
PubMed Identifier
25540298
Citation
Biercevicz AM, Akelman MR, Fadale PD, Hulstyn MJ, Shalvoy RM, Badger GJ, Tung GA, Oksendahl HL, Fleming BC. MRI volume and signal intensity of ACL graft predict clinical, functional, and patient-oriented outcome measures after ACL reconstruction. Am J Sports Med. 2015 Mar;43(3):693-9. doi: 10.1177/0363546514561435. Epub 2014 Dec 24.
Results Reference
background
PubMed Identifier
26585668
Citation
Riboh JC, Saltzman BM, Yanke AB, Cole BJ. Human Amniotic Membrane-Derived Products in Sports Medicine: Basic Science, Early Results, and Potential Clinical Applications. Am J Sports Med. 2016 Sep;44(9):2425-34. doi: 10.1177/0363546515612750. Epub 2015 Nov 19.
Results Reference
background
PubMed Identifier
10638766
Citation
Baeten D, Van den Bosch F, Elewaut D, Stuer A, Veys EM, De Keyser F. Needle arthroscopy of the knee with synovial biopsy sampling: technical experience in 150 patients. Clin Rheumatol. 1999;18(6):434-41. doi: 10.1007/s100670050134.
Results Reference
background
Learn more about this trial
Bio ACL Reconstruction Amnion Collagen Matrix Wrap and Stem Cells
We'll reach out to this number within 24 hrs